Active Ingredient: EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: SYMFI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 600MG;300MG;300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022142
Product Number: 001
Approval Date: Mar 22, 2018
Applicant Holder Full Name: MYLAN LABORATORIES LTD
Marketing Status:
Prescription
Patent and Exclusivity Information